There are 2789 resources available
653O - Pembrolizumab (pembro) vs placebo as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Patient-reported outcomes (PRO) in KEYNOTE-564
Presenter: Toni Choueiri
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
LBA30 - Single-dose carboplatin followed by involved-node radiotherapy as curative treatment for seminoma stage IIA/B: Efficacy results from the international multicenter phase II trial SAKK 01/10
Presenter: Alexandros Papachristofilou
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
340O - Radiotherapy is associated with deletion signatures that contribute to poor survival outcomes in cancer patients
Presenter: Emre Kocakavuk
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
341O - A phase 0 ‘Trigger’ trial of CDK4/6 plus ERK1/2 inhibitors in recurrent glioblastoma
Presenter: Nader Sanai
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
342O - Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
Presenter: Bart Neyns
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
LBA56 - Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study
Presenter: Thomas Seufferlein
Session: Proffered Paper session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA57 - Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC)
Presenter: Thierry Conroy
Session: Proffered Paper session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
1376O - The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)
Presenter: Beate Rau
Session: Proffered Paper session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
1372O - CLDN 18.2-targeted CAR-T cell therapy in patients with cancers of the digestive system
Presenter: Changsong Qi
Session: Proffered Paper session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Omid Hamid
Session: Stay at the bench or move to the bedside: What is the role for neoadjuvant therapy in melanoma today?
Resources:
Slides
Webcast